Lu Li
Stock Analyst at UBS
(2.91)
# 2,655
Out of 4,455 analysts
26
Total ratings
80%
Success rate
11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Rated: Hold | $17 → $12 | $13.79 | -12.98% | 7 | May 7, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $375 | $374.41 | +0.16% | 2 | May 6, 2026 | |
| VCYT Veracyte | Maintained: Buy | $48 → $52 | $60.49 | -14.04% | 6 | May 6, 2026 | |
| DHR Danaher | Maintained: Buy | $250 | $196.19 | +27.43% | 1 | Apr 22, 2026 | |
| FLGT Fulgent Genetics | Maintained: Buy | $35 → $22 | $19.96 | +10.22% | 3 | Mar 2, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $8 → $6 | $5.88 | +2.04% | 7 | Feb 25, 2026 |
QuidelOrtho
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $13.79
Upside: -12.98%
Waters
May 6, 2026
Maintained: Hold
Price Target: $330 → $375
Current: $374.41
Upside: +0.16%
Veracyte
May 6, 2026
Maintained: Buy
Price Target: $48 → $52
Current: $60.49
Upside: -14.04%
Danaher
Apr 22, 2026
Maintained: Buy
Price Target: $250
Current: $196.19
Upside: +27.43%
Fulgent Genetics
Mar 2, 2026
Maintained: Buy
Price Target: $35 → $22
Current: $19.96
Upside: +10.22%
Myriad Genetics
Feb 25, 2026
Maintained: Hold
Price Target: $8 → $6
Current: $5.88
Upside: +2.04%